Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 15/20 | 0.39 |
| ▸ | F2 | P00734 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24729593 | 0.90 | KLKB1 (0.39) | KLKB1F2 | |
| SCHEMBL27033952 | 0.90 | KLKB1 (0.41) | KLKB1F2 | |
| SCHEMBL29958776 | 0.90 | KLKB1 (0.41) | KLKB1F2 | |
| SCHEMBL24729571 | 0.87 | KLKB1 (0.39) | KLKB1F2 | |
| SCHEMBL24729588 | 0.86 | KLKB1 (0.40) | KLKB1 | |
| SCHEMBL29927451 | 0.86 | KLKB1 (0.40) | KLKB1 | |
| SCHEMBL29879530 | 0.85 | KLKB1 (0.39) | KLKB1F2 | |
| SCHEMBL29305441 | 0.85 | KLKB1 (0.39) | KLKB1F2 | |
| SCHEMBL24729487 | 0.85 | KLKB1 (0.41) | KLKB1 | |
| SCHEMBL29927229 | 0.85 | KLKB1 (0.41) | KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4308227-A1 | IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN | Takeda Pharmaceutical Company Limited (JP) | 2024-01-24 | — | — | EP | disclosed |
| CN-117396473-A | Imidazopyridinyl inhibitors of plasma kallikrein | 武田药品工业株式会社 | 2024-01-12 | — | — | CN | disclosed |
| WO-2022197755-A1 | IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2022-09-22 | — | — | WO | disclosed |
| WO-2022197755-A1 | IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2022-09-22 | — | — | WO | disclosed |